Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
US Department of Justice
McKinsey
Mallinckrodt
Fuji
Boehringer Ingelheim
Healthtrust
Julphar
Deloitte

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,962,028

« Back to Dashboard

Which drugs does patent 8,962,028 protect, and when does it expire?

Patent 8,962,028 protects ULTRAVATE and is included in one NDA.

This patent has fourteen patent family members in fourteen countries.
Summary for Patent: 8,962,028
Title:Topical steroid composition and method
Abstract: Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include a halobetasol material comprising halobetasol or its pharmaceutically acceptable salts, esters, and solvates; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate. Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include 0.05% halobetasol propionate; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate.
Inventor(s): Johnson; Keith A. (Durham, NC), Popp; Karl F. (Schodack Landing, NY)
Assignee: MiCal Pharmaceuticals LLC--H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limited Liability Company (San Diego, CA)
Application Number:13/921,833
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery; Formulation; Device;

Drugs Protected by US Patent 8,962,028

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Sun Pharm Industries ULTRAVATE halobetasol propionate LOTION;TOPICAL 208183-001 Nov 6, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y USE OF A LOTION CONTAINING HALOBETASOL PROPIONATE FOR THE TREATMENT OF CORTICOSTEROID-RESPONSIVE DERMATOSES INCLUDING PSORIASIS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,962,028

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Philippines 12015500859 ➤ Sign Up
Mexico 2015004863 ➤ Sign Up
South Korea 20150069005 ➤ Sign Up
Japan 2015534980 ➤ Sign Up
India 4160DEN2015 ➤ Sign Up
Hong Kong 1214154 ➤ Sign Up
Eurasian Patent Organization 201590730 ➤ Sign Up
European Patent Office 2919753 ➤ Sign Up
Australia 2013331271 ➤ Sign Up
China 104884043 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Julphar
Johnson and Johnson
McKinsey
Harvard Business School
Fish and Richardson
Cipla
Express Scripts
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot